This is biotech spec, only at phase 2. They are volatile. Not to mention it’s Friday t3 traders getting our on the back of wed announcement.
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-525
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.3¢ |
Change
-0.018(4.86%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 34.0¢ | $582.1K | 1.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 694272 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 223254 | 7 |
View Market Depth
| Last trade - 13.26pm 20/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |